Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| RE49860 | Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient | Johannes Platzek, Gunnar Garke | 2024-03-05 |
| RE49575 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient | Johannes Platzek, Gunnar Garke | 2023-07-11 |
| 11203593 | Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate | Birgit Keil, Franz-Josef Mais, Winfried Joentgen | 2021-12-21 |
| 10662188 | Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate | Birgit Keil, Franz-Josef Mais, Winfried Joentgen | 2020-05-26 |
| 10633356 | Hydrates of substituted 5-fluoro-1H-pyrazolopyridines | Peter Fey, Donald Bierer | 2020-04-28 |
| 10399977 | Process for preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as a pharmaceutical active ingredient | Johannes Platzek, Gunnar Garke | 2019-09-03 |
| 10364229 | Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing | Peter Fey, Donald Bierer | 2019-07-30 |
| 10087183 | Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate | Birgit Keil, Franz-Josef Mais, Winfried Joentgen | 2018-10-02 |
| 10059707 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient | Johannes Platzek, Gunnar Garke | 2018-08-28 |
| 9957232 | 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate | Juergen Stiehl, Katharina Tenbieg, Birgit Keil | 2018-05-01 |
| 9637459 | Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents | Mathias Berwe, Birgit Keil, Edwin Aret, Kerstin Paulus, Wilfried Schwab | 2017-05-02 |
| 9604948 | Process for preparing substituted 5-fluoro-1H-pyrazolopyridines | Peter Fey, Donald Bierer | 2017-03-28 |
| 9340535 | N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate | Wilfried Schwab, Alexander Birkmann, Kurt Vogtli, Dieter Haag, Andreas Lender +2 more | 2016-05-17 |
| 8877933 | Thermodynamically stable form of a tosylate salt | Jana Lenz | 2014-11-04 |
| 8841446 | Medicaments containing vardenafil hydrochloride trihydrate | Peter Serno, Andreas Ohm, Rainer Bellinghausen, Elmer Vollers, Jan-Olav Henck | 2014-09-23 |
| 8492385 | Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof | Jana Lenz | 2013-07-23 |
| 8466280 | Co-crystal compound of rivaroxaban and malonic acid | Karsten Fähnrich, Olaf Queckenberg, Christiane Reute, Birgit Keil, Karen S. Gushurst +1 more | 2013-06-18 |
| 8273876 | Medicaments containing vardenafil hydrochloride trihydrate | Peter Serno, Andreas Ohm, Rainer Bellinghausen, Eimer Vollers, Jan-Olav Henck | 2012-09-25 |
| 8188270 | Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | Jana Lenz, Gerhard Braun, Birgit Keil, Christian Thomas | 2012-05-29 |
| 7977484 | Crystalline form of cyano-1-cyclopropy1-7-1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid | Hubert Rast, Iris Heep, Werner Hallenbach, Jordi Benet-Buchholz | 2011-07-12 |
| 7713980 | Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof | Jana Lenz | 2010-05-11 |
| 6362214 | Thermodynamically stable form of (R)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban) | Karl-Heinz Wahl, Klaus-Peter Voges | 2002-03-26 |
| 5849752 | Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification | Patrick Bosche | 1998-12-15 |
| 5830908 | Crystalline hydrochloride of (R)-(-)-2-(N-4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl-)-but yl!-aminomethyl)-chroman | Oliver Brehm, Michael Conrad, Dietrich Seidel | 1998-11-03 |
| 5599824 | Pharmaceutical preparation containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate | Ahmed Hegasy, Wolfgang M uck, Gerhard Franckowiak, Rango-Rao Kanikanti | 1997-02-04 |